SNK-396

N/A

Report date: 2026/05/11 20:01:57
NME

Base Information

Drug NameSNK-396
Drug Alias NameSNK-396
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHypolipoproteinemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSynerK Pharmatech (Suzhou) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSynerK Pharmatech (Suzhou) Ltd
Inactive CompaniesN/A
Active IndicationsHypolipoproteinemias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A